J Bierau
Overview
Explore the profile of J Bierau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hagenbach M, Bierau J, Cruz A, Koch C, Manso-Diaz G, Buttner K, et al.
Front Vet Sci
. 2024 Nov;
11:1431777.
PMID: 39588200
Introduction: In the diagnostics of orthopedic diseases in the horse, diagnostic imaging often plays a decisive role. Cone beam computed tomography (CBCT) imaging is used in both human and small...
2.
Habets D, Schaper N, Rogozinski H, van Spronsen F, van Rijn M, Bierau J, et al.
JIMD Rep
. 2013 Feb;
3:83-9.
PMID: 23430878
The facilities for neonatal screening, early diagnosis, and effective treatment of isovaleric acidaemia (IVA) have improved greatly over the past decades. Accordingly, IVA patients reach adolescence and may consider having...
3.
Westermann C, Dorland L, van Diggelen O, Schoonderwoerd K, Bierau J, Waterham H, et al.
Mol Genet Metab
. 2011 Aug;
104(3):273-8.
PMID: 21843962
Earlier research on ten horses suffering from the frequently fatal disorder atypical myopathy showed that MADD (multiple acyl-CoA dehydrogenase deficiency) is the biochemical derangement behind atypical myopathy. From five horses...
4.
Bakker J, Bierau J, Drent M
Eur Respir J
. 2010 Oct;
36(3):684-6.
PMID: 20930204
No abstract available.
5.
van Kuilenburg A, Meijer J, Gokcay G, Baykal T, Rubio-Gozalbo M, Mul A, et al.
Nucleosides Nucleotides Nucleic Acids
. 2010 Jun;
29(4-6):509-14.
PMID: 20544545
Dihydropyrimidine dehydrogenase (DPD) deficiency is an autosomal recessive disorder of the pyrimidine degradation pathway. In a patient presenting with convulsions, psychomotor retardation and Reye like syndrome, strongly elevated levels of...
6.
Blok M, van den Bosch B, Jongen E, Hendrickx A, de Die-Smulders C, Hoogendijk J, et al.
J Med Genet
. 2009 Jul;
46(11):776-85.
PMID: 19578034
Background: Mutations in the DNA polymerase-gamma (POLG) gene are a major cause of clinically heterogeneous mitochondrial diseases, associated with mtDNA depletion and multiple deletions. Objective: To determine the spectrum of...
7.
Bakker J, Bierau J, Drent M
Eur Respir J
. 2007 Nov;
30(5):821-2.
PMID: 17978149
No abstract available.
8.
Bierau J, Bakker J, Lindhout M, van Gennip A
Nucleosides Nucleotides Nucleic Acids
. 2006 Oct;
25(9-11):1129-32.
PMID: 17065077
The indication for the determination of both thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphohydrolase is identical (i.e., adverse drug reactions toward mercaptopurines). Therefore, we tested whether or not our standard...
9.
Gilissen L, Derijks L, Verhoeven H, Bierau J, Hooymans P, Hommes D, et al.
Dig Liver Dis
. 2006 Aug;
39(2):182-6.
PMID: 16880012
In a 23-year-old female with colonic Crohn's disease 6-mercaptopurine 100 mg daily (1.7 mg/kg) was added to mesalamine and prednisolone therapy because of ongoing disease activity. One month later she...
10.
Gilissen L, Bierau J, Derijks L, Bos L, Hooymans P, van Gennip A, et al.
Aliment Pharmacol Ther
. 2005 Sep;
22(7):605-11.
PMID: 16181300
Background: In vitro studies suggest interactions between mesalazine (mesalamine) and thiopurines by thiopurine S-methyltransferase (TPMT) inhibition, influencing the balance of hepatotoxic 6-methylmercaptopurine ribonucleotide and immunosuppressive tioguanine (thioguanine) metabolites. Aim: To...